Alexandra Cantley is a managing partner at Polaris Partners, focusing on early-stage biotech and healthcare investments. She joined in 2019 and serves on multiple boards.
At firms with a similar stage, sector and check size.





One email when Alexandra's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckAlexandra Cantley is a managing partner at Polaris Partners, focusing on early-stage biotech and healthcare investments. She joined in 2019 and serves on multiple boards.
Alexandra Cantley invests through Polaris Partners, which writes checks of $500K to $10M at seed, series a.
A warm intro from a founder Polaris Partners backed works best. A short LinkedIn note with one line on traction is the next best route.
research fellowship at Vertex Pharmaceuticals; initial research team at Inzen Therapeutics; Inzen Therapeutics.
Last updated 2026-10-15. Is this you? Ask for a correction.